Thioacetamide

Thioacetamide

SCHEMBL3574228

CC(N)=S.NNC1(N2CCCCC2)OC(=O)N(c2ccccc2)C1=O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.33
GRIN2A Q12879 2/20 0.33
ALDH1A1 P00352 6/20 0.33
MAPT P10636 4/20 0.33
KDM4E B2RXH2 2/20 0.33
TP53 P04637 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
HPGD P15428 2/20 0.32
ALOX15 P16050 2/20 0.32
HSD17B10 Q99714 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 1/20 0.32
HSD11B1 P28845 1/20 0.31
ELANE P08246 1/20 0.31
SLC6A2 P23975 1/20 0.31
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetamide SCHEMBL3579500 0.67 ALDH1A1 (0.35) GRIN1GRIN2AALDH1A1MAPTKDM4E
SCHEMBL3465492 0.62 ELANE (0.53) ALDH1A1HSD11B1ELANEGAA
SCHEMBL11376669 0.61 ELANE (0.42) ALDH1A1HSD11B1ELANEMEN1KMT2A
SCHEMBL3578040 0.60 IDH1 (0.33) GRIN1GRIN2AALDH1A1MAPTKDM4E
Thioacetamide SCHEMBL5747926 0.59 NOTUM (0.38)
SCHEMBL30643574 0.59 GRIN1 (0.43) GRIN1GRIN2AALDH1A1MAPTKDM4E
SCHEMBL2725134 0.57 GRIN1 (0.35) GRIN1GRIN2AALDH1A1MAPTTP53
SCHEMBL3570167 0.57 IDH1 (0.38) GRIN1GRIN2AALDH1A1HSD11B1SLC6A2
Methane SCHEMBL3623097 0.56 GRIN1 (0.34) GRIN1GRIN2AALDH1A1MAPTTP53
Urea SCHEMBL27797099 0.55 NPC1 (0.61) ALDH1A1MAPTKDM4ETP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729269-B2 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy WOCKHARDT LIMITED (IN) 2014-05-20 US disclosed
US-20100144735-A1 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICROBIAL ACTIVITY WITH IMPROVED IN VIVO EFFICACY WOCKHARDT LIMITED 2010-06-10 US disclosed
US-7687627-B2 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy WOCKHARDT LIMITED (IN) 2010-03-30 US disclosed
EP-1664038-A2 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICRIOBIAL ACTIVITY WITH IMPROVED I IN VIVO /I EFFICACY Wockhardt Limited (IN) 2006-06-07 EP disclosed
US-20050143421-A1 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy WOCKHARDT LIMITED 2005-06-30 US disclosed
WO-2005054234-A2 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICRIOBIAL ACTIVITY WITH IMPROVED IN VIVO EFFICACY WOCKHARDT LIMITED (IN) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144735-A1 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICROBIAL ACTIVITY WITH IMPROVED IN VIVO EFFICACY GMPS, MPO, ARG1 GRIN1 3671/4885GRIN2A 4561/4885ALDH1A1 1960/4885
US-20050143421-A1 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy GMPS, MPO, ARG1 GRIN1 3671/4885GRIN2A 4561/4885ALDH1A1 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.